Product Images Gabapentin

This text provides information on dosing, storage, and packaging instructions for Gabapentin tablets, which contain 600 mg of gabapentin USP per film-coated tablet. The medication is only available with a prescription and comes in child-resistant containers. The manufacturer is CSPC Ouyi Pharmaceutical Co., Ltd. and is distributed by Mullan Pharmaceuticals in Pasadena, CA. The accompanying medication guide must be provided to the patient by the pharmacist. The remaining text may indicate expiration or lot information, but it is not entirely clear.*

Gabapentin is a prescription drug provided in the form of film-coated tablets to patients. The dosage information and storage instructions can be found in the package insert given. Each tablet contains 600mg of gabapentin, USP, and is dispensed in tight (USP), child-resistant containers. The manufacturer is Mullan Pharmaceutical Inc., with Rev. 03/2023 as the latest revision. The tablets are manufactured by CSPC Ouyi Pharmaceutical Co., Ltd., Shijiazhuang, Hebei, China, 052160. A medication guide for each patient accompanies the tablets.*

Gabapentin Tablets, USP is a medication available in film-coated tablets that contain 800 mg of gabapentin, USP, and is recommended to be stored at 25°C (77°F). It is to be dispensed in tight (USP), child-resistant containers, and 500 tablets are included per package. Each patient should be provided with a Medication Guide. Dosage information can be found in the package insert for full prescribing information. The manufacturer is Mullan Pharmaceutical Inc. and the medication is produced by CSPC Ouyi Pharmaceutical Co., Ltd. in Shijiazhuang, Hebei, China.*

The text provides information on a study's mean pain score. There were two groups: a placebo group and a Gabapentin group. The study was divided into two stages, the first was a 4-week dose titration period, and the second was a 4-week fixed dose period. The Gabapentin group was given a daily dosage of 3,600mg. The table appears to illustrate the pain score measurements for the Gabapentin group over the course of 8 weeks.*

The text describes a chart or graph that plots the mean pain score over time during a 3-week dose titration period followed by a 4-week fixed dose period. The chart includes three lines representing the placebo group, the group taking 1,800 mg/day of gabapentin, and the group taking 2,400 mg/day of gabapentin. The chart provides a comparison of pain scores over the course of six time points (baseline, 1-5), and includes the letter T, possibly representing the final time point or end of the study.*

This is a table showing some percentages and statistical significance (represented by asterisks) for two studies. There is not enough information to determine what the studies are about or what the percentages represent.*